SuperworthInhibrx Biosciences market cap INBX
Share price times shares outstanding: what the whole company sells for, since 2024.
- Today, Oct 23, 2026
- $1.4B
- Highest close in our data
- $2B
- May 2026
Inhibrx Biosciences is worth $1.4B at the close on Oct 23, 2026, at $93.38 a share.
That is up 66% over the last year.
Its highest close in our data was $2B in May 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.4B | $852.9M | $2B | +18% |
| 2025 | $1.2B | $161.8M | $1.3B | +437% |
| 2024 | $217.3M | $180.4M | $237.5M | n/a |
Against its peers
Companies in Biotechnology nearest Inhibrx Biosciences' size, closest first, today.
| Company | Market cap |
|---|---|
| INBXInhibrx Biosciences | $1.4B |
| MGTXMeiraGTx | $884.6M |
| VCELVericel | $2.2B |
| ADMAAdma Biologics | $2.4B |
| PLXProtalix BioTherapeutics | $205.5M |
| KRYSKrystal Biotech | $9.2B |
| RGENRepligen | $10B |
| TECHBIO-TECHNE | $11.4B |
| Peer median | $2.4B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Inhibrx Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.